Loading... Please wait...

Kenvue Inc. (KVUE) Stock Price, News & Analysis

Currency in USD Disclaimer
$18.18 -$0.24 (-1.3%)
$18.04
$18.59
$17.75
$26.66

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company


  • Altman Z Score 2.13
  • Piotroski Score 7.00
  • Grade Neutral

Company brief: Kenvue Inc. (KVUE)


Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Company Calendar


  • 04/25/2024
  • 05/07/2024
  • 05/22/2024
  • N/A
  • 07/18/2024
  • N/A

Price Target and Rating


  • $20.50
  • $29.00
  • $18.00
  • N/A
  • Neutral
  • N/A
  • N/A

Profitability


  • $0.78
  • 23.58
  • 23.58
  • 23.58
  • $1.66 B

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.


Latest News of KVUE

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.


×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.